Table of Contents
Chemotherapy Research and Practice
Volume 2011 (2011), Article ID 270932, 6 pages
http://dx.doi.org/10.1155/2011/270932
Research Article

Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia

1Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland
2Institute of Infectious Diseases and Public Health, Marche Polytechnic University, 60121 Ancona, Italy
3Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk, Al. Gen. J. Hallera 107, 80-416, Gdansk, Poland

Received 30 October 2010; Revised 14 March 2011; Accepted 15 March 2011

Academic Editor: G. J. Peters

Copyright © 2011 Wioletta Baranska-Rybak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Schlievert, “Role of superantigens in human disease,” Journal of Infectious Diseases, vol. 167, no. 5, pp. 997–1002, 1993. View at Google Scholar · View at Scopus
  2. P. Marrack and J. Kappler, “The staphylococcal enterotoxins and their relatives,” Science, vol. 248, no. 4956, pp. 705–711, 1990. View at Google Scholar · View at Scopus
  3. L. Skov and O. Baadsgaard, “Bacterial superantigens and inflammatory skin diseases,” Clinical and Experimental Dermatology, vol. 25, no. 1, pp. 57–61, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Bunikowski, M. E. Mielke, H. Skarabis et al., “Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 105, no. 4, pp. 814–819, 2000. View at Google Scholar · View at Scopus
  5. T. M. Zollner, T. A. Wichelhaus, A. Hartung et al., “Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis,” Clinical and Experimental Allergy, vol. 30, no. 7, pp. 994–1000, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Strange, L. Skov, S. Lisby, P. L. Nielsen, and O. Baadsgaard, “Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis,” Archives of Dermatology, vol. 132, no. 1, pp. 27–33, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Tokura, F. Furukawa, H. Wakita, H. Yagi, T. Ushijima, and M. Takigawa, “T-cell proliferation to superantigen-releasing Staphylococcus aureus by MHC class II-bearing keratinocytes under protection from bacterial cytolysin,” Journal of Investigative Dermatology, vol. 108, no. 4, pp. 488–494, 1997. View at Google Scholar · View at Scopus
  8. W. Gliński and E. Rudzki, Alergologia dla Lekarzy Dermatologów, Czelej, Lublin, Poland, 2002.
  9. N. S. Tomi, B. Kränke, and E. Aberer, “Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects,” Journal of the American Academy of Dermatology, vol. 53, no. 1, pp. 67–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Jackow, J. C. Cather, V. Hearne, A. T. Asano, J. M. Musser, and M. Duvic, “Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor Vβ gene expansion,” Blood, vol. 89, no. 1, pp. 32–40, 1997. View at Google Scholar · View at Scopus
  11. A. H. Sarris, T. Esgleyes-Ribot, M. Crow et al., “Cytokine loops involving interferon-γ and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?” Blood, vol. 86, no. 2, pp. 651–658, 1995. View at Google Scholar · View at Scopus
  12. R. S. Tan, C. M. Butterworth, H. McLaughlin, S. Malka, and P. Samman, “Mycosis fungoides: a disease of antigen persistence,” British Journal of Dermatology, vol. 91, no. 6, pp. 607–616, 1974. View at Google Scholar · View at Scopus
  13. J. M. Schröder and J. Harder, “Antimicrobial skin peptides and proteins,” Cellular and Molecular Life Sciences, vol. 63, no. 4, pp. 469–486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Zanetti, “Cathelicidins, multifunctional peptides of the innate immunity,” Journal of Leukocyte Biology, vol. 75, no. 1, pp. 39–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. V. R. Reddy, R. D. Yedery, and C. Aranha, “Antimicrobial peptides: premises and promises,” International Journal of Antimicrobial Agents, vol. 24, no. 6, pp. 536–547, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Yamasaki and R. L. Gallo, “Antimicrobial peptides in human skin disease,” European Journal of Dermatology, vol. 18, no. 1, pp. 11–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Braun-Falco, G. Plewig, H. Wolf, and W. Burgdorf, “Dermatologia,” in Springer, W. Gliński and H. Wolskiej, Eds., pp. 590–592, Czelej, Lublin, Poland, 2004. View at Google Scholar
  18. H. Igarashi, H. Fujikawa, H. Usami, S. Kauababa, and T. Morita, “Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins,” Infection and Immunity, vol. 44, no. 1, pp. 175–181, 1984. View at Google Scholar
  19. T. Christensen, “Qualitative test for monitoring coupling completeness in solid phase peptide synthesis using chloranil,” Acta Chemica Scandinavica, vol. 33, pp. 763–776, 1979. View at Google Scholar
  20. G. B. Fields and R. L. Noble, “Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids,” International Journal of Peptide and Protein Research, vol. 35, no. 3, pp. 161–214, 1990. View at Google Scholar
  21. S. Yagi, N. Wakaki, N. Ikeda et al., “Presence of staphylococcal exfoliative toxin A in sera of patients with atopic dermatitis,” Clinical and Experimental Allergy, vol. 34, no. 6, pp. 984–993, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Y. Leung, P. Walsh, R. Giorno, and D. A. Norris, “A potential role for superantigens in the pathogenesis of psoriasis,” Journal of Investigative Dermatology, vol. 100, no. 3, pp. 225–228, 1993. View at Google Scholar · View at Scopus
  23. J. B. Travers, Q. A. Hamid, D. A. Norris et al., “Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis,” Journal of Clinical Investigation, vol. 104, no. 9, pp. 1181–1189, 1999. View at Google Scholar · View at Scopus
  24. Y. Adachi, H. Akamatsu, and T. Horio, “The effect of antibiotics on the production of superantigen from Staphylococcus aureus isolated from atopic dermatitis,” Journal of Dermatological Science, vol. 28, no. 1, pp. 76–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. L. Stevens, Y. Ma, D. B. Salmi, E. McIndoo, R. J. Wallace, and A. E. Bryant, “Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus,” Journal of Infectious Diseases, vol. 195, no. 2, pp. 202–211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Breuer, A. Kapp, and T. Werfel, “Bacterial infections and atopic dermatitis,” Allergy, vol. 56, no. 11, pp. 1034–1041, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Brockow, P. Grabenhorst, D. Abeck et al., “Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus aureus-colonized atopic eczema,” Dermatology, vol. 199, no. 3, pp. 231–236, 1999. View at Google Scholar
  28. H. Luber, S. Amornsiripanitch, and A. W. Lucky, “Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis,” Archives of Dermatology, vol. 124, no. 6, pp. 853–854, 1988. View at Google Scholar
  29. M. I. White and W. C. Nobel, “Consequences of colonization and infection by Staphylococcus aureus in atopic dermatitis,” Clinical and Experimental Dermatology, vol. 11, no. 1, pp. 34–40, 1986. View at Google Scholar · View at Scopus
  30. M. Boguniewicz, H. Sampson, S. B. Leung, R. Harbeck, and D. Y. Leung, “Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 108, no. 4, pp. 651–652, 2001. View at Google Scholar · View at Scopus
  31. C. I. Ewing, C. Ashcroft, A. C. Gibbs, G. A. Jones, P. J. Connor, and T. J. David, “Flucloxacillin in the treatment of atopic dermatitis,” British Journal of Dermatology, vol. 138, no. 6, pp. 1022–1029, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Breuer, S. Häussler, A. Kapp, and T. Werfel, “Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis,” British Journal of Dermatology, vol. 147, no. 1, pp. 55–61, 2002. View at Publisher · View at Google Scholar · View at Scopus